Department of Reproductive Medicine

Maryam Tarsa

Assistant Clinical Professor
Division of Perinatal Medicine

Patient Appointments:
858-657-8745
Administrative Office:
619-543-6906
Email:
mtarsa@ucsd.edu


MD, Albert Einstein College of Medicine, 1998

 

Residency: Department of Reproductive Medicine,
University of California, San Diego,1998-2002

Fellowship:Department of Reproductive Medicine,
University of California, San Diego, 2002-2005

Post Graduate Training: University of California San Diego
Masters in Advanced Studies in Clinical Research 2003-2006

Licensure:California

Board Certification

Board Certified -American Board of Obstetrics and Gynecology- December 2006
Board Certified – American Board of Obstetrics and Gynecology, Maternal-Fetal Medicine- April 2008

Memberships:
Junior Member of American College of Obstetrics and Gynecology, 1998

Member of the Society for Maternal Fetal Medicine, 2003

Presentations:
Wolf, R., Tarsa, M., Cheung, C. Y., Bogic, L. V. Increased VEGF gene expression in human fetal membranes as a mechanism for premature spontaneous rupture of the membranes. Society for Gynecologic Investigation. Scientific Program and Abstracts, 47th Annual Meeting, Chicago, Illinois, March 2000.

Kim, M. J., Tarsa, M., Moore, T. R. and Bogic, L. V. VEGF gene expression is increased in the decidua of preterm preeclamptic patients. Society for Maternal - Fetal Medicine 21st Annual Meeting, Reno, Nevada, February 2001.

Tarsa, M, Moore, TR, Bogic, LV. Proteomic scale protein analysis defines molecular changes associated with PPROM. Mead Johnson Nutritional Western Perinatal Research Conference, Palm Springs, California, January 2002.

Tarsa, M, Hull, AD, Spector SA, Franklin, P. Outcomes in HIV-Infected Pregnant Women Receiving HAART. Society for Maternal-Fetal Medicine, San Francisco, California, February 2003.

Tarsa, M, Hull, AD, Spector, SA, Franklin, P. Impact of Trizivir Therapy in HIV-Infected Pregnant Women. 6th World Congress of Perinatal Medicine, Osaka, Japan, September 2003.

Shirazi, A, Tarsa, M, Scioscia, A, Pretorius, D, Hull, A. Evaluation of the "difficult" posterior fossa with three-dimensional ultrasound. (2004). Society for Maternal-Fetal Medicine, New Orleans, Louisiana, February 2004.

Tarsa, M, Moutaftsi, M, Singh, K, Spector SA. Expression of DC-SIGN on Human Decidua: A Potential Mechanism for Transplacental Transmission of HIV, CMV, and Other Infectious Agents. Oral presentation at the Society for Maternal Fetal Medicine, Reno, Nevada, February 2005.

Jacquelyn Cortez, DO, Maryam Tarsa, MD MAS, Sally Agent, RN RDMS, Thomas Moore, MD, Acarbose vs. Placebo in Treatment of GDMA Randomized Control Trial. Society of Maternal-Fetal Medicine, February 2007, San Francisco.

Maryam Tarsa MD MAS1, Véronique Taché MD1, Shawn Harrity MD21 Department of Reproductive Medicine, University of California, San Dieg 2 Department of Internal Medicine, University of California, San Diego. With Less Work Hours and More Time to Attend Weekly Scheduled Conferences: Do Reproductive Medicine Residents Perform Better Now Than Before? APGO GREOG, 2009

Bibliography:

Tarsa M, Moore TR. Oligohydramnios. In: Protocols for High Risk Pregnancies, 4th Edition. Blackwell Publishing, Massachusetts 2005.

Tarsa M, Pretorius DH, D'Agostini D. 3-Dimensional Obstetric Ultrasound: Tips of the Trade. In: Ultrasound Clinics. Elsevier Saunders, Philadelphia 2006.

Publications

Book Chapters

Tarsa M, Moore TR. Oligohydramnios. In: Protocols for High Risk Pregnancies, 4th
Edition. Blackwell Publishing, Massachusetts 2005. p: 428-433

Tarsa M, Pretorius DH, D’Agostini D. 3-Dimensional Obstetric Ultrasound: Tips of the
Trade. In: Ultrasound Clinics. Elsevier Saunders, Philadelphia 2006. p: 321-334

Abstracts

Tarsa, M, Hull, AD, Spector SA, Franklin, P. Outcomes in HIV-Infected Pregnant
Women Receiving HAART. Society for Maternal-Fetal Medicine, San Francisco,
California, February 2003.

Tarsa, M, Hull, AD, Spector, SA, Franklin, P. Impact of Trizivir Therapy in HIV-Infected
Pregnant Women. 6th World Congress of Perinatal Medicine, Osaka, Japan, September
2003.

Shirazi, A, Tarsa, M, Scioscia, A, Pretorius, D, Hull, A. Evaluation of the “difficult” posterior fossa with three-dimensional ultrasound. (2004). Society for Maternal-Fetal Medicine, New Orleans, Louisiana, February 2004.

Jacquelyn Cortez, DO, Maryam Tarsa, MD MAS, Sally Agent, RN RDMS, Thomas Moore, MD. Acarbose vs. Placebo in Treatment of GDM. A Randomized Control Trial. Society of Maternal-Fetal Medicine, San Francisco February 2007.

Trivedi N, Tarsa M, Hartley C, Levy D, Anton T, Pretorius DH, Quinn K. Congenital cardiac lesions: Prenatal readings versus outcomes. To 2009 AIUM Annual Convention, New York, NY, J Ultrasound Med 28(3):S136-137, 2009.

Review Articles

M.Tarsa and T.F. Kelly. Managing a Pregnancy with Antibodies: A Clinician’s Perspective. Immunohematology, 2008, 24(2): 52-57. Review.

Tache V, Tarsa M, Romine L, Pretrorius, DH. Three-Dimensional Obstetric Ultrasound.
In: Semin Ultrasound CT MR. 2008 Apr;29(2):147-55. Review.

Faculty


Current Fellows in Maternal-Fetal Medicine:

  • Jerasimos Ballas,
  • Richelle Olsen,
  • Hilary Roeder,
  • Andrew Spencer,
  • Lynlee Wolfe